Cook Medical announced today that it received a contract with Vizient covering the company’s endoscopy devices.
The contract enables Cook to continue offering its endoscopy devices at negotiated pricing terms to Vizient members.
“We are honored to have been chosen as an Endoscopy contracted supplier with Vizient,” said Rick Simms, Cook Medical national GPO account executive. “With over 40 years of expertise in the gastroenterology specialty, Cook Medical looks forward to continuing to work with Vizient members and the physicians that treat patients with our endoscopy medical devices.”
Cook Medical offers a range of minimally invasive devices for gastrointestinal (GI) endoscopy to diagnose and treat GI diseases. Several of its products hold FDA breakthrough device designation, including technology for hemostasis and endoscopic ultrasound.
The company said its new contract with Vizient makes its endoscopy products more accessible to more patients.
This agreement went into effect on April 1, 2023. It includes Cook’s full line of endoscopy medical devices, featuring Hemospray endoscopic hemostat. The contract also features products from the following categories:
- Biliary access (long wire & short wire)
- Biliary / pancreatic therapy
- Biopsy, cytology & polypectomy
- Extraction, dilation, drainage stenting
- Stricture management
- Tissue management
- Esophageal, gastric, colonic
- Enteroscopy
- Hemostasis
- Endoscopic ultrasound
- Endobronchial ultrasound
- Endohepatology
- Endosurgery
